Skip to main content
Rebecca Harris
Castle Point MP

Main navigation

  • About Rebecca
    • Rebecca and Expenses
  • News
  • My Campaigns
  • Constituency
    • Resident Survey
    • New Draft Local Plan 2023-2043
    • The Hollies GP Surgery
    • My Priorities for Castle Point
    • Guide to commenting on planning applications
    • Castle Point Boundary Review
    • Helping with the Cost of Living
    • Canvey Lake
    • Canvey Island Flood Defences
    • Useful Local Contacts
    • NEW Dame Rebecca Harris for Castle Point Survey
  • In Parliament
    • Inside UK Parliament Free Guided Tours
    • Role of a Whip
    • School Visits
  • Campaign Responses
    • Assisted Dying
    • Access to Cash
    • Animal Welfare
    • Brexit
    • Cladding: Protecting Tenants & Leaseholders
    • Defence
    • Dementia Support
    • Environment & Climate Change
    • Equality
    • Economy
    • Energy Security
    • Foreign Affairs
    • Illegal Immigration
    • Infected Blood Inquiry
    • Motorists
    • NHS
    • Park Homes £400 Energy Grant
    • Personal Independent Payments (PIP)
    • Post Office Horizon Scandal
    • Safeguarding Our Elections
    • Support Pubs
    • Triple Lock & Support for Pensioners
    • Universal Credit
    • WASPI & Women's State Pension Age
    • Welfare
    • Winter Fuel Payment
  • Green Belt
    • Consultation Responses to Developers
    • Glebelands Nov25
    • Jotmans Farm
    • North Benfleet Hall Farm Development
    • Regulation 19 Consultation - Grey Belt Concerns
    • Say No to Grey Belt Development on Treasured Green Belt Sites
    • Choose the Blinking Owl Site South of the A127 Instead of Treasured Green Belt Sites
  • Contact
    • PRIVACY NOTICE FOR CONSTITUENTS
  • facebook
  • twitter
  • instagram
Rebecca Harris
Castle Point MP

Vaccine UPDATE on Oxford-Astrazenca Vaccine

  • Tweet
  • Share
Wednesday, 3 February, 2021
  • Westminster News

Study shows Oxford-Astrazenca vaccine offers substantial effect in reducing transmission and offering effective protection from a single dose. The Health Secretary has welcomed a study by Oxford University which shows the Oxford-Astrazenca vaccine may have a substantial effect in reducing the transmission of the virus, offering 76 per cent effective protection from a single dose.

Vaccines are our way out of this pandemic, and we are making fantastic progress in protecting the most vulnerable, as we rollout the largest vaccination programme in our nation’s history.

The preliminary research from Oxford is incredibly encouraging – showing that the vaccine also delivers stronger protection in the 12 week gap between doses and no hospitalisations – supporting our strategy. Cutting the chains of transmission is essential if we are to truly defeat this virus and return to our normal way of life, and these findings from Oxford University potentially mark one of the most significant moments in our battle against Covid-19.

For any more information, please visit Oxford Univeristy’s website at: https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval.

Right now we have administered more than 10.1 million vaccines across the UK, which includes 931,204 vaccinations over the last weekend alone - that's 1 in every 60 adults in the whole of the United Kingdom vaccinated in a single weekend.

We have now vaccinated almost 9 in 10 of all those over 80 in the UK, and more than half of those in their 70s have now received a vaccine, meaning we are on track to meet our target of offering the top 4 priority groups a vaccine by mid-February. Every eligible care home with older residents in England has been visited – 10,307 in total – and offered vaccinations to all their residents and staff, a vital milestone in our ongoing race to protect the most vulnerable against the disease.

Overall, we have now secured early access to over 400 million total doses of vaccines for 2021 and 2022, including the additional 40 million vaccines doses from Valneva we ordered this week. This means we will have the Oxford-AstraZenca vaccine manufactured in Oxford, Staffordshire and Wrexham; the Novovax vaccine made in Teesside and the Valneva vaccine, subject to approval, produced in Livingston, Scotland – a great example of what we can achieve together as one United Kingdom.

You may also be interested in

C2C

Castle Point MP, Dame Rebecca Harris demands improvements as GBR Anglia are left in no doubt that current service isn’t good enough

Wednesday, 18 November, 2026
Concerns have mounted over lengthy delays and increased cancellations as c2c deliver poor service on what was one of the country’s best commuter lines.

News Categories

  • Articles
  • Local News
  • Opinions
  • Reports
  • Westminster News

Dame Rebecca Harris Member of Parliament for Castle Point

Footer

  • About RSS
  • Accessibility
  • Cookies
  • Privacy
  • About Rebecca Harris
  • In Parliament
Conservatives
  • facebook
  • twitter
  • instagram
Promoted by James Cutler on behalf of Rebecca Harris, both at 8 Green Road, Benfleet, Essex SS7 5JT Tel: 01268 792992;
Copyright 2026 Rebecca Harris MP. All rights reserved.
Powered by Bluetree